Delivery Order SPE2DB24D2205-SPE2DB25FEFWG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,111.23 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.30 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a completion date of July 31, 2025. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.57 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30. The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which...
- The Defense Logistics Agency awarded a delivery order valued at $27,178.87 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,108.47 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $4.31K delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) on May 6, 2025, with completion scheduled for May 7, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 tablets, with a ceiling value of $4,397.88. This non-competitive, firm fixed-price delivery order is set to be completed by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFWGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,791.04 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on August 5, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is well-positioned as a critical federal medical procurement vendor with an extensive portfolio of delivery orders through the DLA Medical Supply Chain. The company's track record demonstrates capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, from specialty medications to generic drugs, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects AmerisourceBergen's continued role as a primary vendor for federal antifungal medication procurement and broader military healthcare supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.8k | 8/5/25 |